Jason Duncan - Oct 22, 2021 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Signature
/s/ Jason Duncan
Stock symbol
ALBO
Transactions as of
Oct 22, 2021
Transactions value $
-$9,079
Form type
4
Date filed
10/25/2021, 06:30 PM
Previous filing
Jul 26, 2021
Next filing
Jan 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$2.74K -95 -1.24% $28.85 7.57K Oct 22, 2021 Direct F1, F2, F3
transaction ALBO Common Stock Sale -$6.34K -217 -2.87% $29.21 7.36K Oct 25, 2021 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.8350 to $28.8974, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 Represents 509 shares of common stock and 7,063 restricted stock units.
F4 Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
F5 Represents 292 shares of common stock and 7,063 restricted stock units.